The Medical Advisor

Introduction Cancer remains a leading cause of morbidity and mortality worldwide, with an increasing incidence of aggressive and treatment-resistant tumors such as triple-negative breast cancer (TNBC), pancreatic adenocarcinoma, and glioblastoma. Despite significant advances in targeted therapies and immunotherapies, many patients continue to face limited effective options, highlighting an urgent need for novel, affordable, and accessible treatment strategies.  The high cost of oncology drugs-exceeding $150 billion globally in 2022-and the slow pace of new drug approvals further complicate timely patient access to effective therapies. In this context, drug repurposing-the strategy of identifying new therapeutic uses for existing drugs-has emerged as a promising approach to accelerate cancer treatment development while reducing costs and safety risks. Among repurposed candidates , antiparasitic drugs such as fenbendazole, mebendazole, and ivermectin have attracted...

Cancer  kills around 10 million people a year  and is a leading cause of death globally, according to the World Health Organization. Cancer research continues to advance at an unprecedented pace, with new treatments offering hope to millions of patients worldwide.   Credit:  Statista Breast, lung and colon cancer are among the most common, while the number of new cancer cases annually is expected to grow by more than 75% between 2022 and 2050. As we enter 2025, several groundbreaking therapies and innovations—including personalized vaccines, gene-editing technologies, repurposed drugs, and alternative cancer treatments —are reshaping cancer care. Here are some of the most promising breakthroughs to watch for this year: 1. Personalized Cancer Vaccines Cancer vaccines have evolved beyond prevention, with new personalized vaccines targeting individual tumors. These mRNA-based therapies train the immune system to recognize and attack cancer cells, offering a promis...

Can Fenbendazole and Ivermectin play a key role in treating Stage 4 Colorectal Cancer? Several peer-reviewed papers and case studies (below) strongly suggest that it might.  Ivermectin, Fenbendazole and Mebendazole in Cancer: 2024 Peer-Reviewed Protocol in Cancer Ivermectin and Cancer: 15 Anti-cancer Mechanisms of Action FENBENDAZOLE and CANCER - 12 Anti-Cancer Mechanisms of Action Introduction The potential applications of Ivermectin and Fenbendazole in cancer treatment have sparked significant interest online, with growing communities exploring these compounds for therapeutic use. While both have roots in anti-parasitic medicine, emerging research and anecdotal evidence suggest they may offer benefits in combating colorectal cancers. The main goal with this article is to provide as much clear information as possible for someone dealing with colorectal cancer. This article deals with the basis and practical approach to using Fenbendazole and Ivermectin for colorectal cancer. Iverm...